Review



type 1 diabetes (t1d)  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Illumina Inc type 1 diabetes (t1d)
    Summary of external GWAS summary statistics used
    Type 1 Diabetes (T1d), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/baits+covering+the+ebv+type+1+and+2+reference+genomes/pmc09465343-3-0-4
    Average 90 stars, based on 1 article reviews
    type 1 diabetes (t1d) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores"

    Article Title: Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores

    Journal: Human Genetics and Genomics Advances

    doi: 10.1016/j.xhgg.2022.100136

    Summary of external GWAS summary statistics used
    Figure Legend Snippet: Summary of external GWAS summary statistics used

    Techniques Used:

    Related Articles

    other:

    Article Title: Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores
    Article Snippet: Type 1 diabetes (T1D) (Illumina) , Censin et al. , 7982 , 8,996,866 , 949,334 , 0.942.



    Similar Products

    type 1 diabetes  (Sanguine Biosciences Inc)
    90
    Sanguine Biosciences Inc type 1 diabetes
    Type 1 Diabetes, supplied by Sanguine Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/Type+1+Diabetes+(T1D)+Serum/pm28218739-42-0-5
    Average 90 stars, based on 1 article reviews
    type 1 diabetes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    type 1 diabetes t1d  (Galectin Therapeutics)
    86
    Galectin Therapeutics type 1 diabetes t1d
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Type 1 Diabetes T1d, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/pmc12757048-1-7-5
    Average 86 stars, based on 1 article reviews
    type 1 diabetes t1d - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    type 1 diabetes t1d  (MedChemExpress)
    94
    MedChemExpress type 1 diabetes t1d
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Type 1 Diabetes T1d, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/HSD11B1%2C+Human/pm41192517-297-1-34
    Average 94 stars, based on 1 article reviews
    type 1 diabetes t1d - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    type 1 diabetes t1d  (Diabetology)
    86
    Diabetology type 1 diabetes t1d
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Type 1 Diabetes T1d, supplied by Diabetology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/1+diabetes+type/10__14341_slash_dm13237-33-46-56
    Average 86 stars, based on 1 article reviews
    type 1 diabetes t1d - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    type 1 diabetes (t1d)  (Helmholtz Zentrum fur Infektionsforschung GmbH)
    90
    Helmholtz Zentrum fur Infektionsforschung GmbH type 1 diabetes (t1d)
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Type 1 Diabetes (T1d), supplied by Helmholtz Zentrum fur Infektionsforschung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/melanocortin+type+1+receptor++mc1r+/10__1002_slash_eji__202470200-18638-53-30
    Average 90 stars, based on 1 article reviews
    type 1 diabetes (t1d) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    receiver operator curve t1d type 1 diabetes znt8a zinc transporter 8 autoantibodies znt8ra zinc transporter r325 arginine  (Genovis Inc)
    93
    Genovis Inc receiver operator curve t1d type 1 diabetes znt8a zinc transporter 8 autoantibodies znt8ra zinc transporter r325 arginine
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Receiver Operator Curve T1d Type 1 Diabetes Znt8a Zinc Transporter 8 Autoantibodies Znt8ra Zinc Transporter R325 Arginine, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/OpeRATOR+Lyophilized/pm38150393-14-88-89
    Average 93 stars, based on 1 article reviews
    receiver operator curve t1d type 1 diabetes znt8a zinc transporter 8 autoantibodies znt8ra zinc transporter r325 arginine - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    stz streptozotocin t1d type 1 diabetes t2d type 2 diabetes x chen  (Valiant Co Ltd)
    95
    Valiant Co Ltd stz streptozotocin t1d type 1 diabetes t2d type 2 diabetes x chen
    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with <t>T1D</t> ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
    Stz Streptozotocin T1d Type 1 Diabetes T2d Type 2 Diabetes X Chen, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/Streptozotocin/pm36240976-65-107-143
    Average 95 stars, based on 1 article reviews
    stz streptozotocin t1d type 1 diabetes t2d type 2 diabetes x chen - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    type 1 diabetes t1d  (Thermo Fisher)
    86
    Thermo Fisher type 1 diabetes t1d
    Summary of external GWAS summary statistics used
    Type 1 Diabetes T1d, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/pmc09465343-2-0-4
    Average 86 stars, based on 1 article reviews
    type 1 diabetes t1d - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    type 1 diabetes (t1d)  (Illumina Inc)
    90
    Illumina Inc type 1 diabetes (t1d)
    Summary of external GWAS summary statistics used
    Type 1 Diabetes (T1d), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/baits+covering+the+ebv+type+1+and+2+reference+genomes/pmc09465343-3-0-4
    Average 90 stars, based on 1 article reviews
    type 1 diabetes (t1d) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    type 1 diabetes rat model t1d  (Charles River Laboratories)
    90
    Charles River Laboratories type 1 diabetes rat model t1d
    Summary of external GWAS summary statistics used
    Type 1 Diabetes Rat Model T1d, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/type+1+diabetes+(t1d)/rat+carotid+body++cb++type+1+cells/pm32640891-42-0-14
    Average 90 stars, based on 1 article reviews
    type 1 diabetes rat model t1d - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with T1D ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

    Journal: Science Advances

    Article Title: Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function

    doi: 10.1126/sciadv.adz7916

    Figure Lengend Snippet: ( A ) The concentration of fasting serum Galectin-3 in healthy controls (HC, n = 132), Ab − FDR ( n = 76), Ab + FDR ( n = 30), and patients with T1D ( n = 234). Data are expressed as median ± range. ( B ) The mRNA expression levels of Galectin-3 in CD14 + monocytes isolated from patients with T1D and HC ( n = 10), calculated using the 2 −△△Ct method. ( C ) The concentration of fasting serum LPS in HC and T1D groups ( n = 56). Data are expressed as median ± range. ( D ) Correlation between serum levels of Galectin-3 and LPS in HC and patients with T1D. ( E to J ) The THP-1 cell line, THP-1–cell induced macrophages, and the RAW 264.7 cell line were treated with LPS (100 ng/ml) or vehicle for 24 hours. The mRNA expression levels of Galectin-3 [(E), (G), and (I)] and the protein concentration of Galectin-3 in the supernatant [(F), (H), and (J)] were measured. Data in (E) to (J) are representative of at least three independent experiments with similar results. Data are expressed as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

    Article Snippet: However, the significance of circulating Galectin-3 in type 1 diabetes (T1D) remains unclear.

    Techniques: Concentration Assay, Expressing, Isolation, Protein Concentration

    Summary of external GWAS summary statistics used

    Journal: Human Genetics and Genomics Advances

    Article Title: Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores

    doi: 10.1016/j.xhgg.2022.100136

    Figure Lengend Snippet: Summary of external GWAS summary statistics used

    Article Snippet: Type 1 diabetes (T1D) (Affymetrix) , Censin et al. , 5516 , 8,996,866 , 934,712 , 0.885.

    Techniques:

    Summary of external GWAS summary statistics used

    Journal: Human Genetics and Genomics Advances

    Article Title: Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores

    doi: 10.1016/j.xhgg.2022.100136

    Figure Lengend Snippet: Summary of external GWAS summary statistics used

    Article Snippet: Type 1 diabetes (T1D) (Illumina) , Censin et al. , 7982 , 8,996,866 , 949,334 , 0.942.

    Techniques: